Preparation of coated nanoparticles for a new mucosal vaccine delivery system

被引:177
作者
Borges, O
Borchard, G
Verhoef, JC
de Sousa, A
Junginger, HE
机构
[1] Leiden Amsterdam Ctr Drug Res, Div Pharmaceut Technol, NL-2300 RA Leiden, Netherlands
[2] Univ Coimbra, Fac Pharm, Ctr Pharmaceut Studies, Pharmaceut Technol Lab, P-3000295 Coimbra, Portugal
关键词
chitosan; sodium alginate; ovalbumin adsorption; coated nanoparticles; mucosal vaccination;
D O I
10.1016/j.ijpharm.2005.04.037
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been found that the adsorption of antigens onto chitosan particles is an easy and unique mild loading process suitable to be used with vaccines. In order to increase the stability of this particles and to prevent an immediate desorption in gastrointestinal fluids, a coating process with sodium alginate was developed. One of the challenges of this developing process was to keep the particles in the nanosized range in order to be taken up by M-cells of the Peyer's patches. The observed inversion of the particles' zeta potential values after coating suggested the presence of an alginate coating layer. These results were confirmed by FTIR and DSC techniques. Additionally, in vitro release studies showed that the presence of the alginate layer around the particles was able to prevent a burst release of loaded ovalbumin and to improve the stability of the nanoparticles in simulated intestinal fluid at 37 degrees C. The optimisation of the coating process resulted in 35% (w/w) for the loading capacity of the coated particles. SEM investigations confirmed a suitable size of the coated nanoparticles for the uptake by M-cells. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 35 条
  • [1] Alpar HO, 1998, STP PHARMA SCI, V8, P31
  • [2] Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs
    Berthold, A
    Cremer, K
    Kreuter, J
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (01) : 17 - 25
  • [3] Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles:: preparation, characterization, and preliminary in vivo studies
    Bivas-Benita, M
    Laloup, M
    Versteyhe, S
    Dewit, J
    De Braekeleer, J
    Jongert, E
    Borchard, G
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 266 (1-2) : 17 - 27
  • [4] Oral vaccination of animals with antigens encapsulated in alginate microspheres
    Bowersock, TL
    HogenEsch, H
    Suckow, M
    Guimond, P
    Martin, S
    Borie, D
    Torregrosa, S
    Park, H
    Park, K
    [J]. VACCINE, 1999, 17 (13-14) : 1804 - 1811
  • [5] Production of alginate microspheres by internal gelation using an emulsification method
    Chan, LW
    Lee, HY
    Heng, PWS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) : 259 - 262
  • [6] Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres
    Cho, NH
    Seong, SY
    Chun, KH
    Kim, YH
    Kwon, IC
    Ahn, BY
    Jeong, SY
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) : 215 - 224
  • [7] Protein immobilization in crosslinked alginate microparticles
    Coppi, G
    Iannuccelli, V
    Leo, E
    Bernabei, MT
    Cameroni, R
    [J]. JOURNAL OF MICROENCAPSULATION, 2002, 19 (01) : 37 - 44
  • [8] Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells
    de Vos, P
    Hoogmoed, CG
    Busscher, HJ
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 60 (02): : 252 - 259
  • [9] BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM
    ELDRIDGE, JH
    STAAS, JK
    MEULBROEK, JA
    MCGHEE, JR
    TICE, TR
    GILLEY, RM
    [J]. MOLECULAR IMMUNOLOGY, 1991, 28 (03) : 287 - 294
  • [10] Esquisabel A, 2000, J MICROENCAPSUL, V17, P363